超微量分析法を用いたプロスタノイドの臨床薬学的研究

DOI Web Site Web Site 被引用文献2件 参考文献39件

書誌事項

タイトル別名
  • Establishment of Microanalysis of Prostaglandin Metabolites by GC/MS and Its Clinical Application
  • チョウビリョウ ブンセキホウ オ モチイタ プロスタノイド ノ リンショウ ヤクガクテキ ケンキュウ

この論文をさがす

抄録

We established microdetermination methods of prostaglandin (PG) metabolites by GC-selected ion monitoring (GC-SIM) and applied them to the clinical investigations. At first the microdetermination of Δ17-6-keto-PGF1α, a hydrolyzed metabolite of PGI2, is described. An authentic Δ17-6-keto-PGF1α was prepared from eicosapentaenoic acid (EPA) incubated with a homogenate from the bovine aortic intima. [18O]Δ17-6-Keto-PGF1α was synthesized to obtain an internal standard for GC-SIM of Δ17-6-keto-PGF1α. A good linear response over the range of 10 pg-5 ng was demonstrated. Chromatographic conditions using a MP-65HT column presented nearly baseline separation of Δ17-6-keto-PGF1α and 6-keto-PGF1α. Furthermore, a monoclonal antibody against cis-3-hexen-1-ol was prepared and used to separate and/or concentrate Δ17-6-keto-PGF1α in the human blood sera. Using the prepared immunoaffinity columns of this antibody, Δ17-6-keto-PGF1α was clearly detected in the human blood sera by GC/MS analysis. We were able to detect Δ17-6-keto-PGF1α of the amount ranging from 6 to 26 pg/ml in the human blood plasma. The present method can be applied to the determination of Δ17-6-keto-PGF1α in the human urine and plasma. Diabetes mellitus induces platelet alterations such as hyperaggregation. Variations in PG production seem to be related to this phenomenon but the changes in PG levels remain unclear. So we microanalyzed the 11-dehydrothromboxane B2 (TXB2) and 2, 3-dinor-6-keto-PGF1α, which were stable metabolites of TXA2 and PGI2, in the urine and investigated the relationship between the thromboxane/prostacyclin (TX/PGI) ratio and diabetes mellitus. The TX/PGI ratio in the urine of diabetics was higher than that of healthy volunteers. In murine, the TX/PGI ratio of STZ-induced mice was also higher than that of non-induced mice. The ratio of db/db mice also increased with the progress of diabetes mellitus. Furthermore, we investigated the relationship between the retinal vein occlusion (RVO), a thrombotic disease in which the retinal vein is blocked by blood aggregations, and the TX/PGI ratio. The TX/PGI level in patients with the RVO, who were not combine diabetes, was significantly higher than that in healthy volunteers. One of the causes of the RVO may be due to the variation of thromboxane production. This GC-SIM method can be used to determine the TX/PGI ratio in the urine.

収録刊行物

  • 薬学雑誌

    薬学雑誌 119 (1), 61-80, 1999

    公益社団法人 日本薬学会

被引用文献 (2)*注記

もっと見る

参考文献 (39)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ